Literature DB >> 3771090

Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet.

S Yamashita, Y Matsuzawa, K Tokunaga, S Fujioka, S Tarui.   

Abstract

Uric acid metabolism was investigated in 27 overweight subjects, 11 men (176 +/- 30 percent of ideal body weight) and 16 women (169 +/- 20 percent of ideal body weight). They were all hospitalized and treated with low-calorie diets (1,500-800 kcal/day) with gradual reduction of total calorie intake; exercise therapy (walking, and riding a bicycle ergometer) was added to this regimen afterwards. On admission, serum levels of uric acid were significantly elevated to 9.2 +/- 1.9 mg/dl in males (control 5.1 +/- 0.8 mg/dl) (P less than 0.001) and 6.8 +/- 1.9 mg/dl in females (control 4.4 +/- 1.0 mg/dl) (P less than 0.001), while the ratios (percentages) of uric acid clearance (CuA) to creatinine clearance (Ccr) were significantly reduced to 4.0 +/- 2.1 percent in males (control 10.8 +/- 2.2 percent) (P less than 0.001) and 5.2 +/- 3.1 percent in females (control 11.8 +/- 2.9 percent) (P less than 0.001). Urinary urate excretions were also lower in obese subjects than in controls. These data suggest that hyperuricemia in obese people is mainly attributed to an impaired renal clearance of uric acid rather than overproduction. In the course of weight reduction by a low-calorie diet, CuA/Ccr ratios gradually rose up to almost normal levels and serum levels of uric acid fell without significant changes in creatinine clearance. This increase of CuA/Ccr ratio was also preserved after starting exercise therapy. The normalization of urate excretion was observed even at the phase when their body weight was not fully reduced. Although the underlying mechanism of the impaired urate excretion in obese patients and its improvement during weight reduction is as yet unclear, hyperuricemia associated with obesity can be treated very well only with appropriate diet therapy and in most cases there is no need for drug therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3771090

Source DB:  PubMed          Journal:  Int J Obes


  45 in total

1.  Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study.

Authors:  Wolfgang Rathmann; Burkhard Haastert; Andrea Icks; Guido Giani; Jeffrey M Roseman
Journal:  Eur J Epidemiol       Date:  2007-05-05       Impact factor: 8.082

2.  The relationship between body mass index and uric acid: a study on Japanese adult twins.

Authors:  Kentaro Tanaka; Soshiro Ogata; Haruka Tanaka; Kayoko Omura; Chika Honda; Kazuo Hayakawa
Journal:  Environ Health Prev Med       Date:  2015-06-03       Impact factor: 3.674

3.  Population Impact Attributable to Modifiable Risk Factors for Hyperuricemia.

Authors:  Hyon K Choi; Natalie McCormick; Na Lu; Sharan K Rai; Chio Yokose; Yuqing Zhang
Journal:  Arthritis Rheumatol       Date:  2019-12-03       Impact factor: 10.995

Review 4.  Update on the pathophysiology and management of uric acid renal stones.

Authors:  Jon-Emile S Kenny; David S Goldfarb
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

5.  Combined effect of hyperuricemia and overweight/obesity on the prevalence of hypertension among US adults: result from the National Health and Nutrition Examination Survey.

Authors:  G-M Han; S Gonzalez; D DeVries
Journal:  J Hum Hypertens       Date:  2014-05-01       Impact factor: 3.012

6.  Lumbar epidural lipomatosis is associated with visceral fat and metabolic disorders.

Authors:  Shingo Morishita; Yoshiyasu Arai; Toshitaka Yoshii; Kenichiro Sakai; Takashi Hirai; Atsushi Okawa
Journal:  Eur Spine J       Date:  2018-05-02       Impact factor: 3.134

7.  Effects of Low-Fat, Mediterranean, or Low-Carbohydrate Weight Loss Diets on Serum Urate and Cardiometabolic Risk Factors: A Secondary Analysis of the Dietary Intervention Randomized Controlled Trial (DIRECT).

Authors:  Chio Yokose; Natalie McCormick; Sharan K Rai; Na Lu; Gary Curhan; Dan Schwarzfuchs; Iris Shai; Hyon K Choi
Journal:  Diabetes Care       Date:  2020-09-02       Impact factor: 19.112

8.  Association of Serum Uric Acid with Cardiovascular Disease in Taiwanese Patients with Primary Hypertension.

Authors:  Tsung-Yuan Yang; Chih-Yuan Fang; Jung-Sheng Chen; Helen L Po; Li-Ping Chou; Chih-Yeng Chiang; Kwo-Chang Ueng
Journal:  Acta Cardiol Sin       Date:  2015-01       Impact factor: 2.672

9.  Determinants of serum uric acid levels in an adult general population: results from the Moli-sani Study.

Authors:  Sara Magnacca; Simona Costanzo; Amalia De Curtis; Augusto Di Castelnuovo; Marco Olivieri; Chiara Cerletti; Giovanni de Gaetano; Maria Benedetta Donati; Licia Iacoviello
Journal:  Clin Rheumatol       Date:  2020-07-16       Impact factor: 2.980

10.  Obesity Paradox in Recurrent Attacks of Gout in Observational Studies: Clarification and Remedy.

Authors:  Uyen-Sa D T Nguyen; Yuqing Zhang; Qiong Louie-Gao; Jingbo Niu; David T Felson; Michael P LaValley; Hyon K Choi
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-04       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.